Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects

Clinical Biochemistry

Volumn 39, Issue 3, 2006, Pages 303-308

  Saito, Katsuhiko ^a   Moriya, Hiroyuki ^b   Sawaguchi, Takeru ^b   Hayakawa, Takako ^b   Nakahara, Seiya ^a   Goto, Akira ^a   Arimura, Yoshiaki ^a   Imai, Kohzoh ^a   Kurosawa, Nahoko ^b   Owada, Eiji ^b   Miyamoto, Atsushi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Genotyping; Haplotype; Linkage disequilibrium; Single nucleotide polymorphism; UDP glucuronocyltransferase 2B7

Indexed keywords

GLUCURONOSYLTRANSFERASE;

ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC CODE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; JAPAN; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; EXONS; GENE FREQUENCY; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 33644958925     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.01.002     Document Type: Article

References (26)

1. P.I. Mackenzie, I.S. Owens, and B. Burchell The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Pharmacogenetics 7 1997 255 269
2. J.S. Carrier, D. Turgeon, K. Journault, D.W. Hum, and A. Belanger Isolation and characterization of the human UGT2B7 gene Biochem. Biophys. Res. Commun. 272 2000 616 621
3. M. Riedy, J.Y. Wang, A.P. Miller, A. Buckler, J. Hall, and M. Guida Genomic organization of the UGT2b gene cluster on human chromosome 4q13 Pharmacogenetics 10 2000 251 260
4. C. Jin, J.O. Miners, K.J. Lillywhite, and P.I. Mackenzie Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs J. Pharmacol. Exp. Ther. 264 1993 475 479
5. B.L. Coffman, G.R. Rios, C.D. King, and T.R. Tephly Human UGT2B7 catalyzes morphine glucuronidation Drug Metab. Dispos. 25 1997 1 4
6. O. Barbier, D. Turgeon, and C. Girard 3′-azido-3′- deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7) Drug Metab. Dispos. 28 2000 497 502
7. B.L. Coffman, C.D. King, G.R. Rios, and T.R. Tephly The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268) Drug Metab. Dispos. 26 1998 73 77
8. W.E. Gall, G. Zawada, and B. Mojarrabi Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7 J. Steroid Biochem. Mol. Biol. 70 1999 101 108
9. V.M. Samokyszyn, W.E. Gall, and G. Zawada 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7 J. Biol. Chem. 275 2000 6908 6914
10. C.R. Bhasker, W. McKinnon, and A. Stone Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance Pharmacogenetics 10 2000 679 685
11. M. Holthe, P. Klepstad, and K. Zahlsen Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy Eur. J. Clin. Pharmacol. 58 2002 353 356
12. T. Hirota, I. Ieiri, and H. Takane Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy Drug Metab. Dispos. 31 2003 677 680
13. A. Radominska-Pandya, J.M. Little, and P.J. Czernik Human UDP-glucuronosyltransferase 2B7 Curr. Drug Metab. 2 2001 283 298
14. M. Holthe, T.N. Rakvag, and P. Klepstad Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients Pharmacogenomics J. 3 2003 17 26
15. W.E. Evans, and H.L. McLeod Pharmacogenomics-Drug disposition, drug targets, and side effects N. Engl. J. Med. 348 2003 538 549
16. B.S. Shastry SNPs and haplotypes: genetic markers for disease and drug response (review) Int. J. Mol. Med. 11 2003 379 382
17. M.B. Sawyer, F. Innocenti, and S. Das A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine Clin. Pharmacol. Ther. 73 2003 566 574
18. J.W. Lampe, J. Bigler, A.C. Bush, and J.D. Potter Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y) Cancer Epidemiol. Biomarkers Prev. 9 2000 329 333
19. K. Saito, S. Miyake, and H. Moriya Detection of the four sequence variations of MDR1 gene using TaqMan MGB probe based real-time PCR and haplotype analysis in healthy Japanese subjects Clin. Biochem. 36 2003 511 518
20. L. Excoffier, and M. Slatkin Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population Mol. Biol. Evol. 12 1995 921 927
21. M. Slatkin, and L. Excoffier Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm Heredity 76 1996 377 383
22. M. Stephens, N.J. Smith, and P. Donnelly A new statistical method for haplotype reconstruction from population data Am. J. Hum. Genet. 68 2001 978 989
23. M. Saeki, Y. Saito, and H. Jinno Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population Drug Metab. Dispos. 32 2004 1048 1054
24. Y. Ishii, A.J. Hansen, and P.I. Mackenzie Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter Mol. Pharmacol. 57 2000 940 947
25. K. Toide, Y. Takahashi, and H. Yamazaki Hepatocyte nuclear factor-1alpha is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers Drug Metab. Dispos. 30 2002 613 615
26. Y. Duguay, C. Baar, F. Skorpen, and C. Guillemette A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity Clin. Pharmacol. Ther. 75 2004 223 233